During the past decade, Tohoku University School of Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tohoku University School of Medicine" #1 sponsor was "Gynecologic Oncology Group" with 4 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "GOG Foundation" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Tohoku University" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tohoku University School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Linical Co., Ltd." with 2 trials as a collaborator, "Japan Clinical Oncology Group" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Tohoku University School of Medicine" are "Fallopian Tube Clear Cell Adenocarcinoma" (2 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (2 trials), "Fallopian Tube Mucinous Adenocarcinoma" (2 trials), "Fallopian Tube Serous Adenocarcinoma" (2 trials) and "Fallopian Tube Transitional Cell Carcinoma" (2 trials). Many other conditions were trialed in "Tohoku University School of Medicine" in a lesser frequency.

Most popular intervention types in "Tohoku University School of Medicine" are "Drug" (17 trials), "Other" (9 trials), "Biological" (6 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Carboplatin" (6 trials), "Laboratory Biomarker Analysis" (6 trials), "Paclitaxel" (5 trials) and "Cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Tohoku University School of Medicine" are 12 trials for "Female" genders and 9 trials for "All" genders.

Currently, there are NaN active trials in "Tohoku University School of Medicine". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Tohoku University School of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tohoku University School of Medicine, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".